| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2001) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | L03AB10 |
| UNII: | G8RGG88B68 |
Pharmacology
| Primary Target | |
|---|---|
| Interferon-α/β receptor | |
| interferon α/β receptor 1 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 4 | D008545 | ClinicalTrials |
| Melanoma | 4 | D008545 | ClinicalTrials |
| Hepatitis C, Chronic | 4 | D019698 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Hepatitis D | 3 | D003699 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 3 | D020522 | ClinicalTrials |
| Hepatitis B, Chronic | 3 | D019694 | ClinicalTrials |
| Thrombocythemia, Essential | 3 | D013920 | ClinicalTrials |
| Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
| Neoplasm Metastasis | 3 | D009362 | ClinicalTrials |
| Osteosarcoma | 3 | D012516 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | D015464 | ClinicalTrials |
| Hepatitis | 3 | D006505 | ClinicalTrials |
| Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome | 3 | D000163 | ClinicalTrials |
| Polycythemia Vera | 3 | D011087 | ClinicalTrials |
| Primary Myelofibrosis | 3 | D055728 | ClinicalTrials |
| Skin Neoplasms | 2 | D012878 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Carcinoid Tumor | 2 | D002276 | ClinicalTrials |
| Glioma | 2 | D005910 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Neurofibroma, Plexiform | 2 | D018318 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Craniopharyngioma | 2 | D003397 | ClinicalTrials |
| Neurofibromatosis 1 | 2 | D009456 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Leukemia-Lymphoma, Adult T-Cell | 2 | D015459 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 215647-85-1 |
| ChEMBL | CHEMBL1201561 |
| FDA SRS | G8RGG88B68 |
| Guide to Pharmacology | 7462 |
CONTENTS